Skip to content

Management of Pythium Keratitis

To see the efficacy of topical Linezolid 0.2%as a monotherapy in patients with Pythium Keratitis in comparison with the combination therapy of Linezolid 0.2% and Azithromycin 1% administered topically.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020741
Enrollment
86
Registered
2019-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H160- Corneal ulcer

Interventions

Intervention1: Linezolid 0.2%: Use this drop in patients of pythium keratits. Topically every hourly for 2 weeks followed by 2 hourly till the time of resolution Control Intervention1: combination th

Sponsors

LV Prasad Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All cases with microbial keratitis confirmed on smears and/or culture as Pythium by Microbiologist. 2.Size of infiltrate less or equal to 8 mm excluding the tentacles. 3.Had not used previously Azithromycin or linezolid 4.Ready to give consent 5.Consent for regular follow-up 6.More than 18 years

Exclusion criteria

Exclusion criteria: 1.Mixed infection on smears or cultures 2.Known Allergy to Linezolid or Azithromycin 3.Size of infiltrate > 8 mm 4.Not willing to come for regular follow-up or admission or giving consent

Design outcomes

Primary

MeasureTime frame
Ulcer completely resolved on medical therapy or application of tissue adhesive for thinning.Timepoint: Ulcer completely resolved on medical therapy or application of tissue adhesive for thinning.

Secondary

MeasureTime frame
Number of patients undergone therapeutic Penetrating keratoplasty (TPK) for worsening of infection.Timepoint: 1 month, 3 months and 6 months

Countries

India

Contacts

Public ContactDrBhupesh Bagga

LV Prasad Eye Institute

bhupesh@lvpei.org04030612615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026